B

PriceBiodexa Pharmaceuticals

BDRX

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Historical stock price chart and annual return over the past years

-100%

5 years

% Total

BDRX
-84%

5 years

Annual Return

BDRX